niagenbioscience.com (NAGE) - Year-over-year earnings per share growth for the last twelve months
The modernization of Chromadex Corp (NAGE) laboratories ensures a steady output of components without interruptions. The quarterly EPS change clearly confirms this trend, with the current value standing at -128.20. The growth of biohacking and new data on brain health are driving demand for Niagen, while the high margins and patent protection of Tru Niagen support the issuer's financial stability.
NAGE (ChromaDex): analytical breakdowns and indicator data
- market value and analyst target forecast:
- market capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
- earnings and valuation multiples information:
NAGE - Profit After Payment of Taxes|Expected Profit Chromadex Corp|NAGE - Business Payback Period|Forward P/E Multiple Chromadex Corp|NAGE - Price/Earnings to Growth Multiple|EV/EBITDA Multiple ChromaDex Corp.|NAGE - Income before deduction of interest, taxes and amortization|Earnings per share for the last twelve months ChromaDex|NAGE - Earnings per share for the trailing year|Year-over-year earnings per share growth for the last twelve months niagenbioscience.com|NAGE - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Chromadex Corp
- sales and revenue indicators:
Basic company analysis:niagenbioscience.com - NAGE
Minimizing fundamental risks requires analyzing the dynamics of net earnings per share compared to the previous quarter. This metric measures the rate of real income generation, stripped of one-time factors and debt burdens. For Chromadex Corp (NAGE), this indicator reflects the efficiency of implementing costly ESG standards and sustainable raw materials. The vector of quarterly EPS growth allows for the identification of the trend's inflection point. Analyzing this curve helps synchronize investments with the business cycle phase.
Analysis of competing companies
Intuitive Surgical (ISRG) - Year-over-year earnings per share growth for the last twelve months|DHR - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months BDX|STE (steris.com) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months West Pharmaceutical Services, Inc. (WST)|BAX (Baxter Corp) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Masimo Personal Health MASI|Year-over-year earnings per one share growth for the last 12 months STVN|TFX - Year-over-year earnings per share growth for the last twelve months|MMSI - Quarterly EPS earnings growth|Envista Holdings Corporation (NVST) - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ICU Medical|XRAY (dentsplysirona.com) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months LeMaitre Corp LMAT|Year-over-year earnings per share growth for the last twelve months AtriCure (ATRC)|STAAR Surgical - Year-over-year earnings per share growth for the last 12 months|ZimVie Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months ANGO (AngioDynamics Inc)|CERS - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Alpha Teknova Inc TKNO|monogramorthopedics.com (MGRM) - Year-over-year earnings per share growth for the last twelve months|STSS - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months InfuSystem Holdings, Inc.|UTMD (Utah Medical Products, Inc.) - Year-over-year earnings per share growth rate for the last twelve months|Year-over-year earnings per share growth for the last twelve months KORU Medical Systems, Inc. (KRMD)|Nyxoah S.A - Year-over-year earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Microbot Medical Inc. MBOT|Net earnings per share growth for the trailing year Pro-Dex, Inc.|Zentek Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Elutia ELUT|MLSS (Milestone Scientific Inc.) - Year-over-year net earnings per share growth for the last 12 months|NXGL (NEXGEL, Inc.) - Year-over-year earnings per share growth for the last twelve months|RVP (Retractable Tech) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months HBIO (Harvard Bioscience, Inc.)|Year-over-year net earnings per share growth for the last 12 months FEMY (Femasys)|MHUA - Earnings per share growth in annualized terms for the last twelve months|Predictive Oncology Corp - Year-over-year net earnings per share growth for the last 12 months|CJMB - Year-over-year net earnings per share growth for the last 12 months|ATRI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months NeuroMetrix NURO
